Ranked by rounds participated in, from announcements in Sep 18, 2026 – Oct 17, 2026. Lead counts include only confirmed lead roles.
New companies 24 · Follow-on 0
Stages: Series A 8, Seed 6, Series C+ 4, Series B 3, Pre-seed 2, Undisclosed 1
Clueso $10M Series AHyLight €13M Funding roundNous Research $90M Series BNew companies 14 · Follow-on 1
Stages: Series B 5, Series C+ 4, Series A 3, Pre-seed 1, Seed 1, Undisclosed 1
TypeSafe AI $870M Series AArena $200M Series BVesta $30M Series BNew companies 9 · Follow-on 0
Stages: Series A 3, Series B 3, Series C+ 3, Undisclosed 1
Abby Care $82M Series CArena $200M Series BVinci $250M Series BNew companies 6 · Follow-on 1
Stages: Series B 3, Undisclosed 2, Series A 1, Series C+ 1
RapidCanvas $29M Series BOrigin Undisclosed UndisclosedScimplify $25M Strategic financingNew companies 6 · Follow-on 1
Stages: Series A 2, Series C+ 2, Undisclosed 2, Pre-seed 1
Modal Labs $750M Series DMinerva Humanoids Undisclosed Pre-SeedMelius $20M Series ANew companies 7 · Follow-on 0
Stages: Series B 3, Series C+ 3, Seed 1
Stuut $52.5M Series BHestus, Inc. $7.4M SeedMetaview $60M Series CNew companies 6 · Follow-on 0
Stages: Series C+ 2, Growth 1, Seed 1, Series A 1, Series B 1
Abby Care $82M Series CTypeSafe AI $870M Series AMecka $60M Series BNew companies 5 · Follow-on 1
Stages: Series A 3, Seed 1, Series B 1, Series C+ 1
Arena $200M Series BZomint $3.7M SeedAvarra $17M Series ANew companies 4 · Follow-on 1
Stages: Series C+ 3, Series A 1, Series B 1
Estuary Biotherapeutics $93M Series AOMass Therapeutics $310M Series CArmadin $255.5M Series BNew companies 3 · Follow-on 1
Stages: Series C+ 3, Series A 1, Series B 1
Abby Care $82M Series CSavvy Wealth $100M Series CRightway $155M Series ENew companies 5 · Follow-on 0
Stages: Seed 2, Series A 1, Series B 1, Series C+ 1
Modal Labs $750M Series DArmadin $255.5M Series BSolcoa Industries $75M Seed financing; equity, debt, and equipment financingNew companies 5 · Follow-on 0
Stages: Series B 3, Pre-seed 1, Undisclosed 1
Soufflé Therapeutics $135M Series BBoldfit >₹4B Series BMiter $40M Series BNew companies 4 · Follow-on 0
Stages: Series B 2, Seed 1, Undisclosed 1
CapGrid ₹462.8M Pre-Series BCircle ₹250M SeedSol $4M Funding roundNew companies 4 · Follow-on 0
Stages: Series B 2, Series C+ 2
Modal Labs $750M Series DMultiply Labs $75M Series BVarda $251M Series DNew companies 4 · Follow-on 0
Stages: Series B 3, Seed 1
Mecka $60M Series BStuut $52.5M Series BNous Research $90M Series BNew companies 3 · Follow-on 1
Stages: Series B 2, Series C+ 1, Undisclosed 1
Mecka $60M Series BNous Research $90M Series BNscale $3.4B Pre-IPO convertible loan notesNew companies 3 · Follow-on 1
Stages: Series B 2, Seed 1, Series C+ 1
Savvy Wealth $100M Series CSpiko $90M Series BAugmeta $3M SeedNew companies 3 · Follow-on 1
Stages: Pre-seed 1, Series A 1, Series B 1, Series C+ 1
Armadin $255.5M Series BBigHat Biosciences $75M Series CPrime Minute $15M Pre-SeedNew companies 4 · Follow-on 0
Stages: Seed 1, Series A 1, Series B 1, Series C+ 1
Charter Space $5M SeedIPID $16M Series AFootprint $25M Series BNew companies 4 · Follow-on 0
Stages: Seed 3, Series A 1
Dextr AI $6.7M SeedIPID $16M Series ASoteris Undisclosed SeedNew companies 3 · Follow-on 0
Stages: Series B 2, Undisclosed 1
RapidCanvas $29M Series BScimplify $25M Strategic financingEma $77M Series BNew companies 3 · Follow-on 0
Stages: Series B 1, Series C+ 1, Undisclosed 1
OMass Therapeutics $310M Series CSalience Labs $125M Series BCSignum £2.6M Follow-on fundingNew companies 3 · Follow-on 0
Stages: Pre-seed 1, Series A 1, Series C+ 1
Solvera $6.3M Pre-seedMetaview $60M Series CRayon €10M Series ANew companies 3 · Follow-on 0
Stages: Undisclosed 2, Seed 1
Scimplify $25M Strategic financingParallel Loop $6.6M SeedGravity $15M Funding roundNew companies 3 · Follow-on 0
Stages: Growth 1, Pre-seed 1, Undisclosed 1
Affinity Labs $2M Pre-seed funding including grantAdaptavate £4M Funding package (first close)Productive Machines Undisclosed Growth investmentNew companies 2 · Follow-on 1
Stages: Series B 2, Series C+ 1
Modal Labs $750M Series DNous Research $90M Series BArmadin $255.5M Series BNew companies 3 · Follow-on 0
Stages: Series A 1, Series B 1, Series C+ 1
Modal Labs $750M Series DArmadin $255.5M Series BRestate $20M Series ANew companies 3 · Follow-on 0
Stages: Seed 1, Series A 1, Undisclosed 1
Mesa School of Business ₹1.1B Series A and venture debtGravity $15M Funding roundEDT $2.4M Pre-Series ANew companies 3 · Follow-on 0
Stages: Series B 2, Series C+ 1
Soufflé Therapeutics $135M Series BVinci $250M Series BDevoted Health $555M Series GNew companies 2 · Follow-on 1
Stages: Pre-seed 1, Series B 1, Undisclosed 1
Vinci $250M Series BEfficient Computer $100M Additional fundingPrime Minute $15M Pre-Seed“—” in Led means every role for that investor in this period is undisclosed; it does not mean zero leads. New companies counts the first participation in a company in our records; follow-on counts later participation.